SynthesisJournal of gastrointestinal cancer2012

Systematic review of escalated imatinib doses compared with sunitinib or best supportive care, for the treatment of people with unresectable/metastatic gastrointestinal stromal tumours whose disease has progressed on the standard imatinib dose.

Jennifer Hislop et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.